Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China
Authors:
Open Access
- 15 May 2024
- journal article
- research article
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 10 (1) , 45-54
Abstract
Objective: This study aims to investigate the prevalence of familial cerebral cavernous malformations (FCCMs) in first-degree relatives (FDRs) using familial screening, to describe the distribution of initial symptoms, lesion count on cranial MRI and pathogenic gene in patients. Methods: Patients with multiple CCMs who enrolled from the Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in China database were considered as probands and FDRs were recruited. Cranial MRI was performed to screen the CCMs lesions, and whole-exome sequencing was performed to identify CCM mutations. MRI and genetic screening were combined to diagnose FCCM in FDRs, and the results were presented as prevalence and 95% CIs. The Kaplan-Meier (KM) method was used to calculate the cumulative incidence of FCCM. Results: 33 (76.74%) of the 43 families (110 FDRs) were identified as FCCM (85 FDRs). Receiver operating characteristic analysis revealed three lesions on T2-weighted imaging (T2WI) were the strong indicator for distinguishing probands with FCCM (sensitivity, 87.10%; specificity, 87.50%). Of the 85 FDRs, 31 were diagnosed with FCCM, resulting in a prevalence of 36.5% (26.2%–46.7%). In families with FCCMs, the mutation rates for CCM1, CCM2 and CCM3 were 45.45%, 21.21% and 9.09%, respectively. Furthermore, 53.13% of patients were asymptomatic, 17.19% were intracranial haemorrhage and 9.38% were epilepsy. The mean age of symptom onset analysed by KM was 46.67 (40.56–52.78) years. Conclusion: Based on MRI and genetic analysis, the prevalence of CCMs in the FDRs of families with FCCMs in China was 36.5%. Genetic counselling and MRI screening are recommended for FDRs in patients with more than three CCM lesions on T2WI.Keywords
Funding Information
- Fujian Province High level Neuromedical Center Construction Fund (HLNCC-FJFY-003)
- National Natural Science Foundation of China (8227051360)
- Technology Platform Construction Project of Fujian Province (2020Y2003, 2021Y2001)
This publication has 38 references indexed in Scilit:
- A novel KRIT1/CCM1 mutation accompanied by a NOTCH3 mutation in a Chinese family with multiple cerebral cavernous malformationsneurogenetics, 2023
- Clinicoradiologic data of familial cerebral cavernous malformation with age‐related disease burdenAnnals of Clinical and Translational Neurology, 2023
- Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort studyNeuroradiology, 2022
- Molecular diagnostic workflow, clinical interpretation of sequence variants, and data repository procedures in 140 individuals with familial cerebral cavernous malformationsHuman Mutation, 2019
- Could propranolol be beneficial in adult cerebral cavernous malformations?Neurosurgical Review, 2019
- Review of familial cerebral cavernous malformations and report of seven additional familiesAmerican Journal of Medical Genetics Part A, 2016
- Detection of Novel Mutation in Ccm3 Causes Familial Cerebral Cavernous MalformationsJournal of Molecular Neuroscience, 2015
- High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one‐third of probands are minorsMolecular Genetics & Genomic Medicine, 2014
- CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletionsneurogenetics, 2013
- Genotype–phenotype correlations in cerebral cavernous malformations patientsAnnals of Neurology, 2006